Sunshine Biopharma Inc — Quarterly Financial Statistics (NASDAQ:SBFM)

Financials

Cash from operating activities -3.41 M-1.71 M-1.27 M-727.8 K-1.62 M -5.33 M Cash from investing activities -439.3 K-176.02 K-491.78 K-118.29 K-50.21 K -836.31 K Cash from financing activities 1.97 M338.14 K3.61 M75.54 K724.5 K 4.75 M Free cash flow -3.51 M-1.93 M-1.82 M-761.94 K-1.66 M -6.17 M

Haberler

Sunshine Biopharma board authorized to consider reverse stock split

Sunshine Biopharma kazancı $0,10 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Sunshine Biopharma earnings missed by $0.10, revenue fell short of estimates

Sunshine Biopharma hisseleri Kanada Sağlık Bakanlığı’nın Domperidon onayı sonrası yükseldi

Sunshine Biopharma stock rises after Health Canada approval for Domperidone

Sunshine Biopharma’nın yan kuruluşu ilaç için Kanada Sağlık Bakanlığı onayı aldı

Sunshine Biopharma subsidiary receives Health Canada approval for drug

Sunshine Biopharma Kanada’da jenerik doksisiklin lansmanını gerçekleştirdi

Sunshine Biopharma launches generic doxycycline in Canada

Sunshine Biopharma hisseleri kolesterol ilacı Pravastatin’in piyasaya sürülmesiyle yükseldi

Sunshine Biopharma stock soars after launch of cholesterol drug Pravastatin

Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening - Sunshine Biopharma (NASDAQ:SBFM)